Literature DB >> 19719452

Comparison of single vaccination versus revaccination with a modified-live virus vaccine containing bovine herpesvirus-1, bovine viral diarrhea virus (types 1a and 2a), parainfluenza type 3 virus, and bovine respiratory syncytial virus in the prevention of bovine respiratory disease in cattle.

Douglas L Step1, Clinton R Krehbiel, Luis O Burciaga-Robles, Ben P Holland, Robert W Fulton, Anthony W Confer, David T Bechtol, David L Brister, John P Hutcheson, Harold L Newcomb.   

Abstract

Objective-To compare effects of administration of a modified-live respiratory virus vaccine once with administration of the same vaccine twice on the health and performance of cattle. Design-Randomized, controlled trial. Animals-612 mixed-breed male cattle with unknown health histories. Procedures-Cattle were randomly assigned to 1 of 2 treatment groups (single vaccination treatment group [SVAC group] vs revaccination treatment group [REVAC group]) during the preconditioning phase of production. All cattle were given a modified-live respiratory virus vaccine. Eleven days later, REVAC group cattle received a second injection of the same vaccine. During the finishing phase of production, cattle from each treatment group were either vaccinated a third time with the modified-live respiratory virus vaccine or given no vaccine. Health observations were performed daily. Blood and performance variables were measured throughout the experiment. Results-During preconditioning, no significant differences were observed in performance or antibody production between groups. Morbidity rate from bovine respiratory disease was lower for SVAC group cattle; however, days to first treatment for bovine respiratory disease were not different between groups. No significant differences in body weights, daily gains, or dry-matter intake between groups were observed during the finishing phase. Revaccination treatment group cattle had improved feed efficiency regardless of vaccination protocol in the finishing phase. Conclusions and Clinical Relevance-Vaccination once with a modified-live respiratory virus vaccine was as efficacious as vaccination twice in the prevention of bovine respiratory disease of high-risk cattle, although feed efficiency was improved in REVAC group cattle during the finishing period.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19719452     DOI: 10.2460/javma.235.5.580

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.

Authors:  Manuel F Chamorro; Paul H Walz; Thomas Passler; Edzard van Santen; Julie Gard; Soren P Rodning; Kay P Riddell; Patricia K Galik; Yijing Zhang
Journal:  BMC Vet Res       Date:  2015-02-10       Impact factor: 2.741

Review 2.  Bovine Respiratory Disease Vaccination Against Viral Pathogens: Modified-Live Versus Inactivated Antigen Vaccines, Intranasal Versus Parenteral, What Is the Evidence?

Authors:  Manuel F Chamorro; Roberto A Palomares
Journal:  Vet Clin North Am Food Anim Pract       Date:  2020-07       Impact factor: 3.357

3.  Impact of preweaning vaccination on host gene expression and antibody titers in healthy beef calves.

Authors:  Matthew A Scott; Amelia R Woolums; Brandi B Karisch; Kelsey M Harvey; Sarah F Capik
Journal:  Front Vet Sci       Date:  2022-09-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.